SMPD3 and Alzheimer disease: Neurons accelerate Aβ aggregation by releasing extracellular vesicles rich in ceramides, while inhibition or silencing of neutral sphingomyelinase-2 (nSMase2), which is responsible for vesicle secretion, has been shown to improve Aβ plaque formation, slow the pathological progression of AD and improve cognitive function [89].